Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; Analysis Underway with Initial Results Expected in ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Silexion Therapeutics Corp. (SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today ...
After hours: 7:59:51 p.m. EST Loading Chart for SLXN ...
P/E ratio (year end quote, basic EPS) 253.37 259.61 - - P/E ratio (year end quote, diluted EPS) 253.37 259.61 - - Silexion Therapeutics Dividend Calendar Silexion Therapeutics Calendar Indices ...
CURRENC Group Inc. operates fintech platform for e-wallets, financial institutions, and merchants worldwide. The company’s services include merchant payment, global remittance, global bill ...
BSLK Bolt Projects Holdings, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback